Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ABCA1 CL E G H | 19 | 29 | ORPHA:425 | Apolipoprotein A-I deficiency | | | | 191 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ABCC6 CL E G H | 368 | 57 | ORPHA:758 | Pseudoxanthoma elasticum | | | | 415 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ABCG8 CL E G H | 64241 | 13887 | OMIM:210250 | Sitosterolemia 1 | | | | 76 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ACVR1 CL E G H | 90 | 171 | ORPHA:337 | Fibrodysplasia ossificans progressiva | | | | 49 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:201 | Cowden syndrome | | | | 54 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:744 | Proteus syndrome | | | | 54 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ANTXR2 CL E G H | 118429 | 21732 | OMIM:228600 | Hyaline fibromatosis syndrome | | | | 49 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ANTXR2 CL E G H | 118429 | 21732 | ORPHA:2176 | Infantile systemic hyalinosis | | | | 49 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ANTXR2 CL E G H | 118429 | 21732 | ORPHA:2028 | Juvenile hyaline fibromatosis | | | | 49 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | APC CL E G H | 324 | 583 | ORPHA:873 | Desmoid tumor | | | | 3179 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | APOA1 CL E G H | 335 | 600 | ORPHA:425 | Apolipoprotein A-I deficiency | | | | 40 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | APOA2 CL E G H | 336 | 601 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 9 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | APOB CL E G H | 338 | 603 | OMIM:144010 | Hypercholesterolemia, familial, 2 | | | | 356 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | APOE CL E G H | 348 | 613 | ORPHA:412 | Dysbetalipoproteinemia | | | | 39 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | APOE CL E G H | 348 | 613 | ORPHA:158029 | Sea-blue histiocytosis | | | | 39 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ASAH1 CL E G H | 427 | 735 | ORPHA:333 | Farber disease | | | | 78 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ASAH1 CL E G H | 427 | 735 | OMIM:228000 | Farber lipogranulomatosis | | | | 78 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ATP2A2 CL E G H | 488 | 812 | OMIM:101900 | Acrokeratosis verruciformis | | | | 86 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ATP2A2 CL E G H | 488 | 812 | ORPHA:218 | Darier disease | | | | 86 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ATP2A2 CL E G H | 488 | 812 | OMIM:124200 | Darier-White disease | | | | 86 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | B2M CL E G H | 567 | 914 | OMIM:241600 | Immunodeficiency 43 | | | | 8 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | BCL2 CL E G H | 596 | 990 | ORPHA:545 | Follicular lymphoma | HP:0040283 - Occasional | | | 1 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | BCL6 CL E G H | 604 | 1001 | ORPHA:545 | Follicular lymphoma | HP:0040283 - Occasional | | | 1 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | BRAF CL E G H | 673 | 1097 | ORPHA:500 | Noonan syndrome with multiple lentigines | | | | 276 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | BRAF CL E G H | 673 | 1097 | ORPHA:840 | Syringocystadenoma papilliferum | | | | 276 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | BTNL2 CL E G H | 56244 | 1142 | ORPHA:797 | Sarcoidosis | HP:0040282 - Frequent | | | 1 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | C4A CL E G H | 720 | 1323 | ORPHA:117 | Behçet disease | | | | 1 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | CCR1 CL E G H | 1230 | 1602 | ORPHA:117 | Behçet disease | | | | | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | CDK4 CL E G H | 1019 | 1773 | ORPHA:99971 | Well-differentiated liposarcoma | | | | 145 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 373 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:31112 | Dermatofibrosarcoma protuberans | | | | 373 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:286 | Vascular Ehlers-Danlos syndrome | | | | 749 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 660 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | COL5A1 CL E G H | 1289 | 2209 | OMIM:130000 | Ehlers-danlos syndrome, type I | | | | 660 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 325 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | COL5A2 CL E G H | 1290 | 2210 | OMIM:130010 | Ehlers-Danlos syndrome, classic type, 2 | | | | 325 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:89843 | Dystrophic epidermolysis bullosa pruriginosa | | | | 263 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:873 | Desmoid tumor | | | | 88 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:91414 | Pilomatrixoma | | | | 88 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | CYLD CL E G H | 1540 | 2584 | ORPHA:211 | Familial cylindromatosis | | | | 126 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | CYLD CL E G H | 1540 | 2584 | ORPHA:867 | Familial multiple trichoepithelioma | | | | 126 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | CYP27A1 CL E G H | 1593 | 2605 | OMIM:213700 | Cerebrotendinous xanthomatosis | | | | 114 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | DACT1 CL E G H | 51339 | 17748 | ORPHA:857 | Townes-Brocks syndrome | | | | 2 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | DDIT3 CL E G H | 1649 | 2726 | ORPHA:99967 | Myxoid/round cell liposarcoma | | | | | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ECM1 CL E G H | 1893 | 3153 | ORPHA:530 | Lipoid proteinosis | | | | 14 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ENPP1 CL E G H | 5167 | 3356 | ORPHA:758 | Pseudoxanthoma elasticum | | | | 151 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | EPHX2 CL E G H | 2053 | 3402 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 1 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | ERAP1 CL E G H | 51752 | 18173 | ORPHA:117 | Behçet disease | | | | 1 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | FAS CL E G H | 355 | 11920 | ORPHA:117 | Behçet disease | | | | 59 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | FBN1 CL E G H | 2200 | 3603 | ORPHA:2833 | Stiff skin syndrome | | | | 1361 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | FERMT3 CL E G H | 83706 | 23151 | OMIM:612840 | Leukocyte adhesion deficiency, type III | | | | 23 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:2396 | Encephalocraniocutaneous lipomatosis | | | | 172 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:1555 | Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome | | | | 175 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | FUS CL E G H | 2521 | 4010 | ORPHA:99967 | Myxoid/round cell liposarcoma | | | | 105 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | G6PC1 CL E G H | 2538 | 4056 | OMIM:232200 | Glycogen storage disease ia | | | | | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GHR CL E G H | 2690 | 4263 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 98 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GJB2 CL E G H | 2706 | 4284 | ORPHA:477 | KID syndrome | | | | 199 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GJB6 CL E G H | 10804 | 4288 | ORPHA:477 | KID syndrome | | | | 56 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GLA CL E G H | 2717 | 4296 | ORPHA:324 | Fabry disease | | | | 291 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GLMN CL E G H | 11146 | 14373 | ORPHA:83454 | Glomuvenous malformation | HP:0040282 - Frequent | | | 37 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GLS CL E G H | 2744 | 4331 | OMIM:618339 | Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development | | | | | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:166350 | Osseous heteroplasia, progressive | | | | 101 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:2762 | Progressive osseous heteroplasia | | | | 101 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:79443 | Pseudohypoparathyroidism type 1A | | | | 101 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:79444 | Pseudohypoparathyroidism type 1C | | | | 101 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:79445 | Pseudopseudohypoparathyroidism | | | | 101 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | HLA-B CL E G H | 3106 | 4932 | ORPHA:117 | Behçet disease | | | | 4 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | HLA-B CL E G H | 3106 | 4932 | ORPHA:3287 | Takayasu arteritis | | | | 4 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:545 | Follicular lymphoma | HP:0040283 - Occasional | | | 2 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:797 | Sarcoidosis | HP:0040282 - Frequent | | | 2 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | HMGA2 CL E G H | 8091 | 5009 | ORPHA:94063 | 12q14 microdeletion syndrome | | | | 2 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | HMGA2 CL E G H | 8091 | 5009 | ORPHA:99971 | Well-differentiated liposarcoma | | | | 2 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IARS2 CL E G H | 55699 | 29685 | ORPHA:436174 | Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome | | | | 25 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IDH1 CL E G H | 3417 | 5382 | ORPHA:163634 | Maffucci syndrome | | | | 15 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IDH1 CL E G H | 3417 | 5382 | ORPHA:296 | Ollier disease | | | | 15 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IDH2 CL E G H | 3418 | 5383 | ORPHA:163634 | Maffucci syndrome | | | | 29 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IDH2 CL E G H | 3418 | 5383 | ORPHA:296 | Ollier disease | | | | 29 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IFNG CL E G H | 3458 | 5438 | OMIM:613254 | Tuberous sclerosis-2 | | | | 23 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IFNGR1 CL E G H | 3459 | 5439 | ORPHA:117 | Behçet disease | | | | 60 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IGH CL E G H | 3492 | 5477 | ORPHA:545 | Follicular lymphoma | HP:0040283 - Occasional | | | 7 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IL10 CL E G H | 3586 | 5962 | ORPHA:117 | Behçet disease | | | | 2 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IL12A CL E G H | 3592 | 5969 | ORPHA:117 | Behçet disease | | | | | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IL12A-AS1 CL E G H | 101928376 | 49094 | ORPHA:117 | Behçet disease | | | | | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IL12B CL E G H | 3593 | 5970 | ORPHA:3287 | Takayasu arteritis | | | | 31 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | IL23R CL E G H | 149233 | 19100 | ORPHA:117 | Behçet disease | | | | 1 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | INSR CL E G H | 3643 | 6091 | ORPHA:2297 | Insulin-resistance syndrome type A | | | | 229 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | KIF11 CL E G H | 3832 | 6388 | ORPHA:2526 | Microcephaly-lymphedema-chorioretinopathy syndrome | | | | 46 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | KIF1B CL E G H | 23095 | 16636 | OMIM:256700 | Neuroblastoma, susceptibility to | . | | | 202 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | KIT CL E G H | 3815 | 6342 | ORPHA:79455 | Cutaneous mastocytoma | | | | 327 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | KLLN CL E G H | 100144748 | 37212 | ORPHA:201 | Cowden syndrome | | | | 1 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | KLRC4 CL E G H | 8302 | 6377 | ORPHA:117 | Behçet disease | | | | | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | KRAS CL E G H | 3845 | 6407 | ORPHA:2396 | Encephalocraniocutaneous lipomatosis | | | | 196 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | LDLR CL E G H | 3949 | 6547 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 2157 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | LEMD3 CL E G H | 23592 | 28887 | ORPHA:94063 | 12q14 microdeletion syndrome | | | | 68 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | LEMD3 CL E G H | 23592 | 28887 | ORPHA:1306 | Buschke-Ollendorff syndrome | | | | 68 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | LEMD3 CL E G H | 23592 | 28887 | ORPHA:1879 | Melorheostosis with osteopoikilosis | | | | 68 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | LPL CL E G H | 4023 | 6677 | OMIM:144250 | Hyperlipidemia, familial combined, 3 | | | | 106 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | MC1R CL E G H | 4157 | 6929 | ORPHA:626 | Large congenital melanocytic nevus | | | | 124 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | MDM2 CL E G H | 4193 | 6973 | ORPHA:99971 | Well-differentiated liposarcoma | | | | 1 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | MEFV CL E G H | 4210 | 6998 | ORPHA:117 | Behçet disease | | | | 281 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | MEFV CL E G H | 4210 | 6998 | ORPHA:3243 | Sweet syndrome | HP:0040281 - Very frequent | | | 281 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | MLX CL E G H | 6945 | 11645 | ORPHA:3287 | Takayasu arteritis | | | | | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | MMP14 CL E G H | 4323 | 7160 | ORPHA:371428 | Multicentric osteolysis-nodulosis-arthropathy spectrum | | | | 2 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | MMP2 CL E G H | 4313 | 7166 | OMIM:259600 | Multicentric osteolysis, nodulosis, and arthropathy | | | | 64 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | MMP2 CL E G H | 4313 | 7166 | ORPHA:371428 | Multicentric osteolysis-nodulosis-arthropathy spectrum | | | | 64 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | MYSM1 CL E G H | 114803 | 29401 | ORPHA:508542 | Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome | | | | | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | | | | 47 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | NOTCH3 CL E G H | 4854 | 7883 | ORPHA:2591 | Infantile myofibromatosis | | | | 144 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | NRAS CL E G H | 4893 | 7989 | ORPHA:626 | Large congenital melanocytic nevus | | | | 102 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | OCRL CL E G H | 4952 | 8108 | OMIM:309000 | Lowe syndrome | | | | 88 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PCSK9 CL E G H | 255738 | 20001 | OMIM:603776 | HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3 | | | | 178 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PDE11A CL E G H | 50940 | 8773 | ORPHA:1359 | Carney complex | | | | 13 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PDGFB CL E G H | 5155 | 8800 | ORPHA:31112 | Dermatofibrosarcoma protuberans | | | | 9 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PDGFRB CL E G H | 5159 | 8804 | ORPHA:2591 | Infantile myofibromatosis | | | | 28 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:201 | Cowden syndrome | | | | 162 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | POMP CL E G H | 51371 | 20330 | OMIM:618048 | Proteasome-Associated autoinflammatory syndrome 2 | | | | 2 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PORCN CL E G H | 64840 | 17652 | ORPHA:2092 | Focal dermal hypoplasia | HP:0040282 - Frequent | | | 20 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PPP1R17 CL E G H | 10842 | 16973 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 2 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1359 | Carney complex | | | | 134 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:109 | Bannayan-Riley-Ruvalcaba syndrome | | | | 948 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:201 | Cowden syndrome | | | | 948 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PTEN CL E G H | 5728 | 9588 | OMIM:158350 | Cowden syndrome 1 | | | | 948 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:65285 | Lhermitte-Duclos disease | | | | 948 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:744 | Proteus syndrome | | | | 948 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PTEN CL E G H | 5728 | 9588 | ORPHA:137608 | Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome | | | | 948 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PTH1R CL E G H | 5745 | 9608 | ORPHA:296 | Ollier disease | | | | 58 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | PTPN11 CL E G H | 5781 | 9644 | ORPHA:500 | Noonan syndrome with multiple lentigines | | | | 291 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | RAF1 CL E G H | 5894 | 9829 | ORPHA:500 | Noonan syndrome with multiple lentigines | | | | 212 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | SALL1 CL E G H | 6299 | 10524 | ORPHA:857 | Townes-Brocks syndrome | | | | 124 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | SDHB CL E G H | 6390 | 10681 | ORPHA:201 | Cowden syndrome | | | | 237 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | SDHC CL E G H | 6391 | 10682 | ORPHA:201 | Cowden syndrome | | | | 147 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | SDHD CL E G H | 6392 | 10683 | ORPHA:201 | Cowden syndrome | | | | 129 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | SEC23B CL E G H | 10483 | 10702 | ORPHA:201 | Cowden syndrome | | | | 60 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | | | | 110 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232220 | Glycogen storage disease ib | | | | 110 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | | | | 110 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | SPRED1 CL E G H | 161742 | 20249 | ORPHA:137605 | Legius syndrome | | | | 136 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | STAT4 CL E G H | 6775 | 11365 | ORPHA:117 | Behçet disease | | | | 2 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | TEK CL E G H | 7010 | 11724 | ORPHA:1059 | Blue rubber bleb nevus | | | | 78 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | TLR4 CL E G H | 7099 | 11850 | ORPHA:117 | Behçet disease | | | | 3 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | TNFRSF11A CL E G H | 8792 | 11908 | ORPHA:2801 | Juvenile Paget disease | | | | 72 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | TNFRSF11B CL E G H | 4982 | 11909 | ORPHA:2801 | Juvenile Paget disease | | | | 44 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | TSC1 CL E G H | 7248 | 12362 | OMIM:191100 | Tuberous sclerosis-1 | | | | 1090 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | TSC2 CL E G H | 7249 | 12363 | OMIM:613254 | Tuberous sclerosis-2 | | | | 2738 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | TTPA CL E G H | 7274 | 12404 | OMIM:277460 | VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF | | | | 62 | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | UBAC2 CL E G H | 337867 | 20486 | ORPHA:117 | Behçet disease | | | | | | |
HP:0200036 | HP:0200036 | Skin nodule | 0 | USF3 CL E G H | 205717 | 30494 | ORPHA:201 | Cowden syndrome | | | | 1 | | |
HP:0200036 | HP:0032217 | Indurated nodule | 1 | CL E G H | | | | | | | | | | |
HP:0200036 | HP:0025554 | Yellow nodule | 1 | CL E G H | | | | | | | | | | |
HP:0200036 | HP:0025529 | Hyperpigmented nodule | 1 | CL E G H | | | | | | | | | | |
HP:0200036 | HP:0025103 | Umbilicated nodule | 1 | CL E G H | | | | | | | | | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | ABCA1 CL E G H | 19 | 29 | ORPHA:425 | Apolipoprotein A-I deficiency | | | | 191 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | ABCC6 CL E G H | 368 | 57 | ORPHA:758 | Pseudoxanthoma elasticum | HP:0040283 - Occasional | | | 415 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | ABCG8 CL E G H | 64241 | 13887 | OMIM:210250 | Sitosterolemia 1 | | | | 76 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | ACVR1 CL E G H | 90 | 171 | ORPHA:337 | Fibrodysplasia ossificans progressiva | HP:0040281 - Very frequent | | | 49 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 54 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:744 | Proteus syndrome | HP:0040281 - Very frequent | | | 54 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | ANTXR2 CL E G H | 118429 | 21732 | OMIM:228600 | Hyaline fibromatosis syndrome | | | | 49 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | ANTXR2 CL E G H | 118429 | 21732 | ORPHA:2176 | Infantile systemic hyalinosis | HP:0040281 - Very frequent | | | 49 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | ANTXR2 CL E G H | 118429 | 21732 | ORPHA:2028 | Juvenile hyaline fibromatosis | HP:0040281 - Very frequent | | | 49 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | APC CL E G H | 324 | 583 | ORPHA:873 | Desmoid tumor | HP:0040281 - Very frequent | | | 3179 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | APOA1 CL E G H | 335 | 600 | ORPHA:425 | Apolipoprotein A-I deficiency | | | | 40 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | APOA2 CL E G H | 336 | 601 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 9 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | APOB CL E G H | 338 | 603 | OMIM:144010 | Hypercholesterolemia, familial, 2 | | | | 356 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | APOE CL E G H | 348 | 613 | ORPHA:412 | Dysbetalipoproteinemia | | | | 39 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | APOE CL E G H | 348 | 613 | ORPHA:158029 | Sea-blue histiocytosis | HP:0040281 - Very frequent | | | 39 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | ASAH1 CL E G H | 427 | 735 | ORPHA:333 | Farber disease | | | | 78 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | ASAH1 CL E G H | 427 | 735 | OMIM:228000 | Farber lipogranulomatosis | | | | 78 | | |
HP:0200036 | HP:0200016 | Acrokeratosis | 1 | ATP2A2 CL E G H | 488 | 812 | OMIM:101900 | Acrokeratosis verruciformis | . | | | 86 | | |
HP:0200036 | HP:0200016 | Acrokeratosis | 1 | ATP2A2 CL E G H | 488 | 812 | ORPHA:218 | Darier disease | HP:0040281 - Very frequent | | | 86 | | |
HP:0200036 | HP:0200016 | Acrokeratosis | 1 | ATP2A2 CL E G H | 488 | 812 | OMIM:124200 | Darier-White disease | . | | | 86 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | B2M CL E G H | 567 | 914 | OMIM:241600 | Immunodeficiency 43 | | | | 8 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:500 | Noonan syndrome with multiple lentigines | HP:0040283 - Occasional | | | 276 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:840 | Syringocystadenoma papilliferum | HP:0040281 - Very frequent | | | 276 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | BTNL2 CL E G H | 56244 | 1142 | ORPHA:797 | Sarcoidosis | HP:0040283 - Occasional | | | 1 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | C4A CL E G H | 720 | 1323 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | 1 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | CCR1 CL E G H | 1230 | 1602 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | CDK4 CL E G H | 1019 | 1773 | ORPHA:99971 | Well-differentiated liposarcoma | HP:0040281 - Very frequent | | | 145 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 373 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:31112 | Dermatofibrosarcoma protuberans | HP:0040281 - Very frequent | | | 373 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:286 | Vascular Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 749 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 660 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | COL5A1 CL E G H | 1289 | 2209 | OMIM:130000 | Ehlers-danlos syndrome, type I | | | | 660 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 325 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | COL5A2 CL E G H | 1290 | 2210 | OMIM:130010 | Ehlers-Danlos syndrome, classic type, 2 | | | | 325 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | COL7A1 CL E G H | 1294 | 2214 | ORPHA:89843 | Dystrophic epidermolysis bullosa pruriginosa | HP:0040283 - Occasional | | | 263 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:873 | Desmoid tumor | HP:0040281 - Very frequent | | | 88 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:91414 | Pilomatrixoma | | | | 88 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | CYLD CL E G H | 1540 | 2584 | ORPHA:211 | Familial cylindromatosis | HP:0040281 - Very frequent | | | 126 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | CYLD CL E G H | 1540 | 2584 | ORPHA:867 | Familial multiple trichoepithelioma | HP:0040281 - Very frequent | | | 126 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | CYP27A1 CL E G H | 1593 | 2605 | OMIM:213700 | Cerebrotendinous xanthomatosis | | | | 114 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | DACT1 CL E G H | 51339 | 17748 | ORPHA:857 | Townes-Brocks syndrome | HP:0040282 - Frequent | | | 2 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | DDIT3 CL E G H | 1649 | 2726 | ORPHA:99967 | Myxoid/round cell liposarcoma | HP:0040281 - Very frequent | | | | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | ECM1 CL E G H | 1893 | 3153 | ORPHA:530 | Lipoid proteinosis | HP:0040281 - Very frequent | | | 14 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | ENPP1 CL E G H | 5167 | 3356 | ORPHA:758 | Pseudoxanthoma elasticum | HP:0040283 - Occasional | | | 151 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | EPHX2 CL E G H | 2053 | 3402 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 1 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | ERAP1 CL E G H | 51752 | 18173 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | 1 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | FAS CL E G H | 355 | 11920 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | 59 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | FBN1 CL E G H | 2200 | 3603 | ORPHA:2833 | Stiff skin syndrome | HP:0040283 - Occasional | | | 1361 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | FERMT3 CL E G H | 83706 | 23151 | OMIM:612840 | Leukocyte adhesion deficiency, type III | | | | 23 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:2396 | Encephalocraniocutaneous lipomatosis | HP:0040281 - Very frequent | | | 172 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | FGFR2 CL E G H | 2263 | 3689 | ORPHA:1555 | Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome | HP:0040281 - Very frequent | | | 175 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | FUS CL E G H | 2521 | 4010 | ORPHA:99967 | Myxoid/round cell liposarcoma | HP:0040281 - Very frequent | | | 105 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | G6PC1 CL E G H | 2538 | 4056 | OMIM:232200 | Glycogen storage disease ia | | | | | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | GHR CL E G H | 2690 | 4263 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 98 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | GLA CL E G H | 2717 | 4296 | ORPHA:324 | Fabry disease | HP:0040281 - Very frequent | | | 291 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | GLS CL E G H | 2744 | 4331 | OMIM:618339 | Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development | | | | | | |
HP:0200036 | HP:0025027 | Osteoma cutis | 1 | GNAS CL E G H | 2778 | 4392 | OMIM:166350 | Osseous heteroplasia, progressive | . | | | 101 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:2762 | Progressive osseous heteroplasia | HP:0040281 - Very frequent | | | 101 | | |
HP:0200036 | HP:0025027 | Osteoma cutis | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:79443 | Pseudohypoparathyroidism type 1A | HP:0040283 - Occasional | | | 101 | | |
HP:0200036 | HP:0025027 | Osteoma cutis | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:79444 | Pseudohypoparathyroidism type 1C | HP:0040283 - Occasional | | | 101 | | |
HP:0200036 | HP:0025027 | Osteoma cutis | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:79445 | Pseudopseudohypoparathyroidism | HP:0040283 - Occasional | | | 101 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | HLA-B CL E G H | 3106 | 4932 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | 4 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | HLA-B CL E G H | 3106 | 4932 | ORPHA:3287 | Takayasu arteritis | HP:0040281 - Very frequent | | | 4 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:797 | Sarcoidosis | HP:0040283 - Occasional | | | 2 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | HMGA2 CL E G H | 8091 | 5009 | ORPHA:94063 | 12q14 microdeletion syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | HMGA2 CL E G H | 8091 | 5009 | ORPHA:99971 | Well-differentiated liposarcoma | HP:0040281 - Very frequent | | | 2 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IARS2 CL E G H | 55699 | 29685 | ORPHA:436174 | Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome | | | | 25 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IDH1 CL E G H | 3417 | 5382 | ORPHA:163634 | Maffucci syndrome | HP:0040282 - Frequent | | | 15 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IDH1 CL E G H | 3417 | 5382 | ORPHA:296 | Ollier disease | HP:0040282 - Frequent | | | 15 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IDH2 CL E G H | 3418 | 5383 | ORPHA:163634 | Maffucci syndrome | HP:0040282 - Frequent | | | 29 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IDH2 CL E G H | 3418 | 5383 | ORPHA:296 | Ollier disease | HP:0040282 - Frequent | | | 29 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IFNG CL E G H | 3458 | 5438 | OMIM:613254 | Tuberous sclerosis-2 | . | | | 23 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IFNGR1 CL E G H | 3459 | 5439 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | 60 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IL10 CL E G H | 3586 | 5962 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | 2 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IL12A CL E G H | 3592 | 5969 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IL12A-AS1 CL E G H | 101928376 | 49094 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IL12B CL E G H | 3593 | 5970 | ORPHA:3287 | Takayasu arteritis | HP:0040281 - Very frequent | | | 31 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | IL23R CL E G H | 149233 | 19100 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | 1 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | INSR CL E G H | 3643 | 6091 | ORPHA:2297 | Insulin-resistance syndrome type A | HP:0040281 - Very frequent | | | 229 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | KIF11 CL E G H | 3832 | 6388 | ORPHA:2526 | Microcephaly-lymphedema-chorioretinopathy syndrome | HP:0040283 - Occasional | | | 46 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | KLLN CL E G H | 100144748 | 37212 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | KLRC4 CL E G H | 8302 | 6377 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | KRAS CL E G H | 3845 | 6407 | ORPHA:2396 | Encephalocraniocutaneous lipomatosis | HP:0040281 - Very frequent | | | 196 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | LDLR CL E G H | 3949 | 6547 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 2157 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | LEMD3 CL E G H | 23592 | 28887 | ORPHA:94063 | 12q14 microdeletion syndrome | HP:0040283 - Occasional | | | 68 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | LEMD3 CL E G H | 23592 | 28887 | ORPHA:1306 | Buschke-Ollendorff syndrome | HP:0040281 - Very frequent | | | 68 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | LEMD3 CL E G H | 23592 | 28887 | ORPHA:1879 | Melorheostosis with osteopoikilosis | HP:0040283 - Occasional | | | 68 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | LPL CL E G H | 4023 | 6677 | OMIM:144250 | Hyperlipidemia, familial combined, 3 | | | | 106 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | MC1R CL E G H | 4157 | 6929 | ORPHA:626 | Large congenital melanocytic nevus | HP:0040283 - Occasional | | | 124 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | MDM2 CL E G H | 4193 | 6973 | ORPHA:99971 | Well-differentiated liposarcoma | HP:0040281 - Very frequent | | | 1 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | MEFV CL E G H | 4210 | 6998 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | 281 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | MLX CL E G H | 6945 | 11645 | ORPHA:3287 | Takayasu arteritis | HP:0040281 - Very frequent | | | | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | MMP14 CL E G H | 4323 | 7160 | ORPHA:371428 | Multicentric osteolysis-nodulosis-arthropathy spectrum | HP:0040282 - Frequent | | | 2 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | MMP2 CL E G H | 4313 | 7166 | OMIM:259600 | Multicentric osteolysis, nodulosis, and arthropathy | | | | 64 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | MMP2 CL E G H | 4313 | 7166 | ORPHA:371428 | Multicentric osteolysis-nodulosis-arthropathy spectrum | HP:0040282 - Frequent | | | 64 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | MYSM1 CL E G H | 114803 | 29401 | ORPHA:508542 | Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome | HP:0040283 - Occasional | | | | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | NAGA CL E G H | 4668 | 7631 | ORPHA:79280 | Alpha-N-acetylgalactosaminidase deficiency type 2 | HP:0040281 - Very frequent | | | 47 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | NOTCH3 CL E G H | 4854 | 7883 | ORPHA:2591 | Infantile myofibromatosis | HP:0040281 - Very frequent | | | 144 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | NRAS CL E G H | 4893 | 7989 | ORPHA:626 | Large congenital melanocytic nevus | HP:0040283 - Occasional | | | 102 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | OCRL CL E G H | 4952 | 8108 | OMIM:309000 | Lowe syndrome | . | | | 88 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | PCSK9 CL E G H | 255738 | 20001 | OMIM:603776 | HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3 | | | | 178 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | PDE11A CL E G H | 50940 | 8773 | ORPHA:1359 | Carney complex | | | | 13 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:31112 | Dermatofibrosarcoma protuberans | HP:0040281 - Very frequent | | | 9 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | PDGFRB CL E G H | 5159 | 8804 | ORPHA:2591 | Infantile myofibromatosis | HP:0040281 - Very frequent | | | 28 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 162 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | POMP CL E G H | 51371 | 20330 | OMIM:618048 | Proteasome-Associated autoinflammatory syndrome 2 | | | | 2 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | PORCN CL E G H | 64840 | 17652 | ORPHA:2092 | Focal dermal hypoplasia | HP:0040282 - Frequent | | | 20 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | PPP1R17 CL E G H | 10842 | 16973 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 2 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1359 | Carney complex | | | | 134 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:109 | Bannayan-Riley-Ruvalcaba syndrome | HP:0040282 - Frequent | | | 948 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 948 | | |
HP:0200036 | HP:0200016 | Acrokeratosis | 1 | PTEN CL E G H | 5728 | 9588 | OMIM:158350 | Cowden syndrome 1 | . | | | 948 | | |
HP:0200036 | HP:0200016 | Acrokeratosis | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:65285 | Lhermitte-Duclos disease | HP:0040282 - Frequent | | | 948 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:744 | Proteus syndrome | HP:0040281 - Very frequent | | | 948 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | PTEN CL E G H | 5728 | 9588 | ORPHA:137608 | Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome | HP:0040281 - Very frequent | | | 948 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | PTH1R CL E G H | 5745 | 9608 | ORPHA:296 | Ollier disease | HP:0040282 - Frequent | | | 58 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | PTPN11 CL E G H | 5781 | 9644 | ORPHA:500 | Noonan syndrome with multiple lentigines | HP:0040283 - Occasional | | | 291 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | RAF1 CL E G H | 5894 | 9829 | ORPHA:500 | Noonan syndrome with multiple lentigines | HP:0040283 - Occasional | | | 212 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | SALL1 CL E G H | 6299 | 10524 | ORPHA:857 | Townes-Brocks syndrome | HP:0040282 - Frequent | | | 124 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | SDHB CL E G H | 6390 | 10681 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 237 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | SDHC CL E G H | 6391 | 10682 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 147 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | SDHD CL E G H | 6392 | 10683 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 129 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | SEC23B CL E G H | 10483 | 10702 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 60 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | | | | 110 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232220 | Glycogen storage disease ib | | | | 110 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | | | | 110 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | SPRED1 CL E G H | 161742 | 20249 | ORPHA:137605 | Legius syndrome | | | | 136 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | STAT4 CL E G H | 6775 | 11365 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | 2 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | TEK CL E G H | 7010 | 11724 | ORPHA:1059 | Blue rubber bleb nevus | HP:0040282 - Frequent | | | 78 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | TLR4 CL E G H | 7099 | 11850 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | 3 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | TNFRSF11A CL E G H | 8792 | 11908 | ORPHA:2801 | Juvenile Paget disease | HP:0040283 - Occasional | | | 72 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | TNFRSF11B CL E G H | 4982 | 11909 | ORPHA:2801 | Juvenile Paget disease | HP:0040283 - Occasional | | | 44 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | TSC1 CL E G H | 7248 | 12362 | OMIM:191100 | Tuberous sclerosis-1 | . | | | 1090 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | TSC2 CL E G H | 7249 | 12363 | OMIM:613254 | Tuberous sclerosis-2 | . | | | 2738 | | |
HP:0200036 | HP:0010732 | Nodular changes affecting the eyelids | 1 | TTPA CL E G H | 7274 | 12404 | OMIM:277460 | VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF | | | | 62 | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | UBAC2 CL E G H | 337867 | 20486 | ORPHA:117 | Behçet disease | HP:0040281 - Very frequent | | | | | |
HP:0200036 | HP:0001482 | Subcutaneous nodule | 1 | USF3 CL E G H | 205717 | 30494 | ORPHA:201 | Cowden syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0200036 | HP:0010606 | Hordeolum | 2 | CL E G H | | | | | | | | | | |
HP:0200036 | HP:0010604 | Cyst of the eyelid | 2 | CL E G H | | | | | | | | | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | ABCA1 CL E G H | 19 | 29 | ORPHA:425 | Apolipoprotein A-I deficiency | | | | 191 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | ABCG8 CL E G H | 64241 | 13887 | OMIM:210250 | Sitosterolemia 1 | | | | 76 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | APOA1 CL E G H | 335 | 600 | ORPHA:425 | Apolipoprotein A-I deficiency | | | | 40 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | APOA2 CL E G H | 336 | 601 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 9 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | APOB CL E G H | 338 | 603 | OMIM:144010 | Hypercholesterolemia, familial, 2 | . | | | 356 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | APOE CL E G H | 348 | 613 | ORPHA:412 | Dysbetalipoproteinemia | HP:0040282 - Frequent | | | 39 | | |
HP:0200036 | HP:0007470 | Periarticular subcutaneous nodules | 2 | ASAH1 CL E G H | 427 | 735 | ORPHA:333 | Farber disease | HP:0040281 - Very frequent | | | 78 | | |
HP:0200036 | HP:0007470 | Periarticular subcutaneous nodules | 2 | ASAH1 CL E G H | 427 | 735 | OMIM:228000 | Farber lipogranulomatosis | . | | | 78 | | |
HP:0200036 | HP:0025014 | Subcutaneous spheroids | 2 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 373 | | |
HP:0200036 | HP:0025014 | Subcutaneous spheroids | 2 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 660 | | |
HP:0200036 | HP:0025014 | Subcutaneous spheroids | 2 | COL5A1 CL E G H | 1289 | 2209 | OMIM:130000 | Ehlers-danlos syndrome, type I | | | | 660 | | |
HP:0200036 | HP:0025014 | Subcutaneous spheroids | 2 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 325 | | |
HP:0200036 | HP:0025014 | Subcutaneous spheroids | 2 | COL5A2 CL E G H | 1290 | 2210 | OMIM:130010 | Ehlers-Danlos syndrome, classic type, 2 | | | | 325 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | CYP27A1 CL E G H | 1593 | 2605 | OMIM:213700 | Cerebrotendinous xanthomatosis | | | | 114 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | EPHX2 CL E G H | 2053 | 3402 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 1 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | G6PC1 CL E G H | 2538 | 4056 | OMIM:232200 | Glycogen storage disease ia | . | | | | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | GHR CL E G H | 2690 | 4263 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 98 | | |
HP:0200036 | HP:0007470 | Periarticular subcutaneous nodules | 2 | IARS2 CL E G H | 55699 | 29685 | ORPHA:436174 | Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome | HP:0040281 - Very frequent | | | 25 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | LDLR CL E G H | 3949 | 6547 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 2157 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | LPL CL E G H | 4023 | 6677 | OMIM:144250 | Hyperlipidemia, familial combined, 3 | HP:0040283 - Occasional | | | 106 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | PCSK9 CL E G H | 255738 | 20001 | OMIM:603776 | HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3 | | | | 178 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | PPP1R17 CL E G H | 10842 | 16973 | OMIM:143890 | Hypercholesterolemia, familial, 1 | | | | 2 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | HP:0040283 - Occasional | | | 110 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232220 | Glycogen storage disease ib | . | | | 110 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | . | | | 110 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | SPRED1 CL E G H | 161742 | 20249 | ORPHA:137605 | Legius syndrome | | | | 136 | | |
HP:0200036 | HP:0001114 | Xanthelasma | 2 | TTPA CL E G H | 7274 | 12404 | OMIM:277460 | VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF | . | | | 62 | | |
HP:0200036 | HP:0010608 | Hordeolum internum | 3 | CL E G H | | | | | | | | | | |
HP:0200036 | HP:0010607 | Hordeolum externum | 3 | CL E G H | | | | | | | | | | |
HP:0200036 | HP:0010605 | Chalazion | 3 | CL E G H | | | | | | | | | | |